calcium carbonate (Tums, Oscal, Oyst-Cal)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Tums. CaCO3

Indications

Contraindications

pregnancy_category :value +

pregnancy_category :value ? 1st trimester

safety_in_lactation :value ?

Dosage

Tabs: 500, 750, 1000 mg

Pharmacokinetics

  • 20% absorbed & eliminated by the kidneys
  • majority is not absorbed & is eliminated in the feces
  • CaCO3 is well absorbed when taken with meals even in patients with achlorhydria

Adverse effects

Drug interactions

Mechanism of action

More general terms

Additional terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, 496
  3. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  4. 4.0 4.1 Greendale G, In: Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 25-28, 2002
  5. Prescriber's Letter 14(3): 2007 Calcium and Vitamin D Supplementation: Who Needs It? Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230304&pb=PRL (subscription needed) http://www.prescribersletter.com
  6. 6.0 6.1 Bolland MJ et al, Vascular events in healthy older women receiving calcium supplementation: Randomized controlled trial, BMJ 2008, 336:262 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18198394
    Prescriber's Letter 15(3): 2008 Calcium Supplementation and Vascular Events Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=240306&pb=PRL (subscription needed) http://www.prescribersletter.com
  7. Prescriber's Letter 15(10): 2008 CHART: Comparison of Oral Calcium Salts GUIDELINES: NAMS Position Statement on the Management of Osteoporosis in Postmenopausal Women GUIDELINES: Diagnosis and Management of Osteoporosis in Canada Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=241008&pb=PRL (subscription needed) http://www.prescribersletter.com
  8. 8.0 8.1 Reid IR et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 2008 Nov 10; 168:2276. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19001206
  9. 9.0 9.1 Bolland MJ et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis. BMJ 2010 Jul 29; 341:c3691 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20671013
    Bolland MJ et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: Reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011 Apr 19; 342:d2040 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21505219
  10. 10.0 10.1 Deprecated Reference

Database